Market Outlook:
With earnings growth troughing and economic data holding up, we expect the outlook for stocks to improve through year-end. Consumers are in good shape and the labour market remains resilient. As a result, we are not expecting a recession in the short run. The most recent Job Openings and Labor Turnover Survey (JOLTS) report confirms that the U.S. labour market has become less tight, which has positive implications for inflation, specifically wage growth going forward.
We believe that incoming economic data should provide the U.S. Federal Reserve with enough cover to hold rates at current or slightly higher levels, thereby alleviating a key headwind for stocks.
In this environment, we expect that dividend growth will become increasingly attractive as rates peak and eventually turn lower. More specifically, we continue to recommend a barbell approach, with technology and medical tech providing growth exposure as well as energy and financials providing cyclical value. In addition, we would note that the more supportive rates backdrop should bode well for rate-sensitive sectors such as real estate and utilities.
While seasonality indicates that we could have a choppy market in September, we believe investors should stay the course in anticipation of a fourth-quarter rally driven by improving fundamentals and a more supportive macro backdrop.
Top Picks:
Chartwell Retirement Residences (CSH.UN TSX)
Purchased at $9.80 Aug. 9, 2023
Chartwell is the largest operator of Retirement homes in Canada. We like the setup for the stock as we enter 2024 when we should see occupancy levels return to pre-pandemic levels. This will not only drive revenue higher due to volumes but also result in margin expansion. These catalysts are expected to drive growth of over 20 per cent in cash flow from operations in 2024 (year over year).
Medtronic (MDT NYSE)
Purchased at US$83.68 on Aug. 23, 2023
Medtronic is a turnaround story, it has an exciting new product cycle that positions the company to exceed guidance over the coming year. Similar to other medtech companies, MDT is benefiting from pent-up demand for elective surgeries and procedures. Trades at 16 times forward earnings compared to many peers at 24 times forward earnings. A dividend yield over three pre cent is an added bonus.
Enbridge (ENB TSX)
Purchased at $46.86 on Aug. 25, 2023
The company recently reported in-line financial results and reaffirmed its financial outlook. We like the stock for its resilient business model and greater than seven per cent dividend yield at current prices. Long-term investors should accumulate shares at these levels to benefit from a growing dividend in 2024 in addition to share price appreciation when interest rates roll back in 2024 and 2025.
| Disclosure | Personal | Family | Portfolio/Fund |
|---|---|---|---|
| CSH.UN TSX | N | N | Y |
| MDT NYSE | N | N | Y |
| ENB TSX | N | N | Y |
Past Picks: September 12, 2022
Granite REIT (GRT.UN TSX)
- Then: $77.19
- Now: $75.47
- Return: -2%
- Total Return: 2%
TransAlta (TA TSX)
- Then: $12.37
- Now: $12.98
- Return: 5%
- Total Return: 7%
Tidewater Midstream (TWM TSX)
- Then: $1.26
- Now: $1.07
- Return: -15%
- Total Return: -11%
Total Return Average: -1%
| Disclosure | Personal | Family | Portfolio/Fund |
|---|---|---|---|
| GRT.UN TSX | N | N | Y |
| TA TSX | N | N | Y |
| TWM TSX | N | N | Y |
Disclaimer
Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. You will usually pay brokerage fees to your dealer if you purchase or sell units/shares of investment funds on the Toronto Stock Exchange or other alternative Canadian trading system (an “Exchange”). If the units/shares are purchased or sold on an Exchange, investors may pay more than the current net asset value when buying and may receive less than the current net asset value when selling them. There are ongoing fees and expenses associated with owning units or shares of an investment fund. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the fund in these documents. Mutual funds and investment funds are not guaranteed, their values change frequently and past performance may not be repeated. Certain statements in this disclosure are forward-looking. Forward-looking statements (“FLS”) are statements that are predictive in nature, depend upon or refer to future events or conditions, or that include words such as “may”, “will”, “should”, “could”, “expect”, “anticipate”, “intend”, “plan”, “believe”, or “estimate”, or other similar expressions. Statements that look forward in time or include anything other than historical information are subject to risks and uncertainties, and actual results, actions or events could differ materially from those set forth in the FLS. FLS are not guarantees of future performance and are by their nature based on numerous assumptions. Although the FLS contained herein are based upon what Middlefield Funds and the portfolio manager believe to be reasonable assumptions, neither Middlefield Funds nor the portfolio manager can assure that actual results will be consistent with these FLS. The reader is cautioned to consider the FLS carefully and not to place undue reliance on FLS. Unless required by applicable law, it is not undertaken, and specifically disclaimed that there is any intention or obligation to update or revise FLS, whether as a result of new information, future events or otherwise.
This material has been prepared for informational purposes only without regard to any particular user’s investment objectives or financial situation. This communication constitutes neither a recommendation to enter into a particular transaction nor a representation that any product described herein is suitable or appropriate for you. Investment decisions should be made with guidance from a qualified professional. The opinions contained in this report are solely those of Middlefield Limited (“ML”) and are subject to change without notice. ML makes every effort to ensure that the information has been derived from sources believed to reliable, but we cannot represent that they are complete or accurate. However, ML assumes no responsibility for any losses or damages, whether direct or indirect which arise from the use of this information. ML is under no obligation to update the information contained herein. This document is not to be construed as a solicitation, recommendation or offer to buy or sell any security, financial product or instrument.
